Page last updated: 2024-12-08

2-hydroxy-1,4-benzoxazin-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-hydroxy-1,4-benzoxazin-3-one: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

HBOA : A benzoxazine bearing hydroxy and oxo substituents at positions 2 and 3 respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID322636
CHEMBL ID457386
CHEBI ID63559
SCHEMBL ID912962
MeSH IDM0401661

Synonyms (22)

Synonym
nsc280714
23520-34-5
nsc-280714
2-hydroxy-2h-1,4-benzoxazin-3(4h)-one
2-hydroxy-1,4-benzoxazin-3-one
hboa
inchi=1/c8h7no3/c10-7-8(11)12-6-4-2-1-3-5(6)9-7/h1-4,8,11h,(h,9,10
CHEMBL457386
chebi:63559 ,
2-hydroxy-4h-1,4-benzoxazin-3-one
2-hydroxy-4h-[1,4]benzoxazin-3-one
SCHEMBL912962
AKOS024287938
2-hydroxy-3,4-dihydro-2h-1,4-benzoxazin-3-one
(r)-2-hydroxy-2h-1,4-benzoxazin-3(4h)-one
DTXSID00314114
Z984801448
Q27132690
hboa;2-hydroxy-1,4-benzoxazin-3-one
BCP31437
2h-1,4-benzoxazin-3(4h)-one, 2-hydroxy-
EN300-65795
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
allelochemicalA class of secondary metabolites developed by many plants to influence the behaviour, growth or survival of herbivores, and thus acting as a defence against herbivory.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
benzoxazine
lactamCyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.
lactolCyclic hemiacetals formed by intramolecular addition of a hydroxy group to an aldehydic or ketonic carbonyl group. They are thus 1-oxacycloalkan-2-ols or unsaturated analogues.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
DIBOA-glucoside biosynthesis713
superpathway of benzoxazinoid glucosides biosynthesis920
superpathway of benzoxazinoid glucosides biosynthesis1020
DIBOA-glucoside biosynthesis813

Bioassays (3)

Assay IDTitleYearJournalArticle
AID338669Antiinflammatory activity in Wistar rat peritoneal mast cells assessed as inhibition of IgE-induced histamine release at 1000 uM treated 10 mins before IgE challenge measured after 5 mins
AID338668Antiinflammatory activity in Wistar rat peritoneal mast cells assessed as inhibition of concanavalin A-induced histamine release at 1000 uM treated 10 mins before concanavalin A challenge measured after 30 mins
AID1103171Antifeedant activity against third-instar larvae of Rhopalosiphum padi assessed as repellency index after 24 hr by feeding choice assay2004Journal of agricultural and food chemistry, May-05, Volume: 52, Issue:9
Chemical basis for the antifeedant activity of natural hydroxamic acids and related compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.81 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]